These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34786740)

  • 1. Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom.
    Loo LK; Salim O; Liang D; Goel A; Sumangala S; Gowda AS; Davies B; Rajabally YA
    Muscle Nerve; 2022 Feb; 65(2):233-237. PubMed ID: 34786740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization.
    Ginanneschi F; Vinciguerra C; Volpi N; Piscosquito G; Barone P; Rossi A
    Immunol Res; 2023 Dec; 71(6):833-838. PubMed ID: 37395901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
    Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
    Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
    Suri V; Pandey S; Singh J; Jena A
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report.
    Smaoui E; Moalla KS; Bouattour N; Farhat N; Sakka S; Daoud S; Damak M; Mhiri C
    Pan Afr Med J; 2024; 47():46. PubMed ID: 38681104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
    García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular complications after COVID-19 vaccination: a series of eight patients.
    Leemans W; Antonis S; De Vooght W; Lemmens R; Van Damme P
    Acta Neurol Belg; 2022 Jun; 122(3):753-761. PubMed ID: 35499704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine.
    Scendoni R; Petrelli C; Scaloni G; Logullo FO
    Hum Vaccin Immunother; 2021 Nov; 17(11):4093-4096. PubMed ID: 34347563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.